Most Recent
Apple plans to appeal the Full Federal Court's decision that Epic Games' misuse of market power lawsuit over it App Store terms should be heard in Australia because the case raises issues of "fundamental public interest".
A COVID-19 business interruption test case that was filed in the Federal Court following a landmark loss for insurers in test case before the NSW Court of Appeal, will be determined along with any appeals by the end of the year, a judge has said.
Singapore-based telecommunications giant Singtel, which owns Optus, has launched a copyright lawsuit seeking discovery from a former vice-president who jumped ship to Telstra.
Christian Porter has appealed a ruling that barred silk Sue Chrysanthou from representing him in his now-settled defamation lawsuit against the ABC over its coverage of historical rape allegations.
The High Court on Friday denied special leave to three unions representing Qantas workers that sought to challenge a Federal Court ruling for the airline in a dispute over the operation of last year's COVID-19 JobKeeper wage subsidy.
The dossier by the woman who accused former Attorney-General Christian Porter of rape has been made public in a case brought by the woman's friend against his star defamation barrister.
Christian Porter and silk Sue Chrysanthou have been ordered to foot the legal bill of a friend of the woman who accused Porter of rape, after she succeeded in having the barrister removed from defamation proceedings the former attorney-general brought against the ABC.
A top intellectual property barrister who has worked on cutting-edge cases that raise novel questions about the patentability of inventions has been appointed to the Federal Court.
Video game developer Epic Games has asked the Full Federal Court to overturn an "illogical" decision sending its competition lawsuit against Apple to California, saying the move would have a "chilling effect" on the enforcement of Australia's competition laws.
A judge has given Generic Health more time to file its evidence in a multimillion-dollar dispute with drug makers Otsuka and Bristol-Myers Squibbs over the delayed launch of generic versions of their antipsychotic drug Abilify, but warned there had to be a cut-off point for preparing the decade-long dispute for trial.